Effects of Dupilumab on Mucus Plugging and Ventilation Defects in Patients with Moderate-to-Severe Asthma : A Randomized, Double-Blind, Placebo-Controlled Trial
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:208 |
|---|---|
| Enthalten in: |
American journal of respiratory and critical care medicine - 208(2023), 9 vom: 01. Nov., Seite 995-997 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Svenningsen, Sarah [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
420K487FSG |
|---|
| Anmerkungen: |
Date Completed 06.11.2023 Date Revised 07.11.2023 published: Print ClinicalTrials.gov: NCT03884842 Citation Status MEDLINE |
|---|
| doi: |
10.1164/rccm.202306-1102LE |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361017863 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361017863 | ||
| 003 | DE-627 | ||
| 005 | 20231226084245.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1164/rccm.202306-1102LE |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1203.xml |
| 035 | |a (DE-627)NLM361017863 | ||
| 035 | |a (NLM)37603097 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Svenningsen, Sarah |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effects of Dupilumab on Mucus Plugging and Ventilation Defects in Patients with Moderate-to-Severe Asthma |b A Randomized, Double-Blind, Placebo-Controlled Trial |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.11.2023 | ||
| 500 | |a Date Revised 07.11.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a ClinicalTrials.gov: NCT03884842 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a dupilumab |2 NLM | |
| 650 | 7 | |a 420K487FSG |2 NLM | |
| 700 | 1 | |a Kjarsgaard, Melanie |e verfasserin |4 aut | |
| 700 | 1 | |a Haider, Ehsan |e verfasserin |4 aut | |
| 700 | 1 | |a Venegas, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Konyer, Norman |e verfasserin |4 aut | |
| 700 | 1 | |a Friedlander, Yonni |e verfasserin |4 aut | |
| 700 | 1 | |a Nasir, Neha |e verfasserin |4 aut | |
| 700 | 1 | |a Boylan, Colm |e verfasserin |4 aut | |
| 700 | 1 | |a Kirby, Miranda |e verfasserin |4 aut | |
| 700 | 1 | |a Nair, Parameswaran |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of respiratory and critical care medicine |d 1994 |g 208(2023), 9 vom: 01. Nov., Seite 995-997 |w (DE-627)NLM074657305 |x 1535-4970 |7 nnns |
| 773 | 1 | 8 | |g volume:208 |g year:2023 |g number:9 |g day:01 |g month:11 |g pages:995-997 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1164/rccm.202306-1102LE |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 208 |j 2023 |e 9 |b 01 |c 11 |h 995-997 | ||